Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Labeled Exploratory Study to Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis

NCT05059509 is registered in ClinicalTrials.gov with Oneness Biotech Co., Ltd. as lead sponsor.

NCT NCT05059509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05059509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Labeled Exploratory Study to Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis
Lead sponsor
Oneness Biotech Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
February 6, 2020
Completion date
March 31, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis